ArticleActa ophthalmologica2022

Clinical benefits and potential risks of adalimumab in non-JIA chronic paediatric uveitis.

Carlyn V Kouwenberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.